stock market screener


Stocks inched upwardFriday after remarks by Federal Reserve Chair Janet Yellen pointed to a rate hike later this month.

The Dow andS&P 500 posted fractionalgains.The blue chips barelyfinishedhigher on the day, up 3 points and staying above 21,000, ending at 21,005.71.

Climbing 0.2% was the Nasdaq composite, to 5870.75.

At our meeting later this month, the committee will evaluate whether employment and inflation are continuing to evolve in line with our expectations, in which case a further adjustment of the federal funds rate would likely be appropriate, Yellen said in a 1 p.m. ET speech at the Executives Club of Chicago.


While Yellen couched her remark in conditional terms that depend on economic data, she preceded it by citinga job market that has been strengthening and inflation that has been rising toward our target of 2% annually.

stock market screener: McEwen Mining Inc.(MUX)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, basic materials shares fell by 1.24 percent. Meanwhile, top losers in the sector included Haynes International, Inc. (NASDAQ: HAYN), down 12 percent, and McEwen Mining Inc (NYSE: MUX), down 9 percent.

  • [By Dan Caplinger]

    The stock market lost more ground on Friday, but major market benchmarks still managed to post healthy gains as 2016 drew to a close. Double-digit percentage gains for the year continued the bull market, and investors generally enjoyed positive momentum despite the sluggish levels of trading activity during the inter-holiday week. Nevertheless, some stocks suffered more precipitous declines, and U.S. Steel (NYSE:X), EnteroMedics (NASDAQ:ETRM), and McEwen Mining (NYSE:MUX) were among the worst performers on the last trading day of the year. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Lisa Levin]

    Basic materials shares climbed 2.06 percent in trading on Wednesday. Meanwhile, top gainers in the sector included Gold Resource Corporation (NASDAQ: GORO), and McEwen Mining Inc (NYSE: MUX).

stock market screener: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.


    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By Keith Speights]

    There are plenty of reasons for investors to like three marijuana stocks in particular — GW Pharmaceuticals (NASDAQ:GWPH), Insys Therapeutics (NASDAQ:INSY), and Aphria (NASDAQOTH:APHQF). In fact, there are at least 661 million reasons. That’s the amount of cash in U.S. dollars that the three companies have combined. Here’s why the cash stockpiles held by GW, Insys, and Apria are important.

  • [By Javier Hasse]

    Check out Part 2 of this article, where Phillips shares a look at some other notable transactions announced last week, featuring Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), Aphria Inc (OTC: APHQF), Invictus MD (OTC: IVITF) and more.

stock market screener: Tobira Therapeutics, Inc.(TBRA)


Advisors’ Opinion:

  • [By Benzinga News Desk]

    Allergan (NYSE: AGN) acquired Akarna Therapeutics global rights to AKN-083 for up-front payment of $50 million. This came just hours after Allergan bought Tobira Therapeutics (NASDAQ: TBRA) for upfront Payment of $28.35 share in cash, up to $49.84 per share in CVRs.

stock market screener: FibroGen, Inc(FGEN)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Good

    The market remains resistant (Rs over Ss and Ns). Brokerages, banks and insurance companies continue their league-leading strength. The Russell 2000 Index is up for the 15th consecutive day. Retail extends yesterday’s strength. Nordstrom (JWN) , Macy’s (M) , Best Buy (BBY) , Target (TGT) , Walmart (WMT) , Foot Locker (FL) and JCPenney (JCP) are strong. First day down for Amazon (AMZN) . Agricultural commodities are lackluster, but soybeans are up another up $0.05 today, up substantially for three days in a row. Speculative biotech (Sage (SAGE) , FibroGen (FGEN) , Acadia Pharmaceuticals (ACAD) and Aerie Pharmaceuticals  (AERI) ) stronger after recent weakness. Ag equipment up big time after the Deere (DE) beat.

    The Bad

Leave a Reply

Your email address will not be published. Required fields are marked *